Skip to main navigation Skip to search Skip to main content

A five-gene model predicts clinical outcome in ER+/PR+, early-stage breast cancers treated with adjuvant tamoxifen.

  • University of Louisville

Research output: Contribution to journal › Article › peer-review

Original languageAmerican English
JournalHormones and Cancer
Volume2
Issue number5
DOIs
StatePublished - Aug 9 2011
Externally publishedYes

Disciplines

  • Medicine and Health Sciences
  • Oncology
  • Pathology
  • Internal Medicine

Cite this